Evaluating the Metabolic Effects of Dietary Nitrate Supplementation
NCT ID: NCT05579262
Last Updated: 2023-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2022-07-08
2023-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose and Response of Dietary Nitrate in Healthy and Active Men
NCT01961427
Beetroot Supplementation and High Intensity Exercise
NCT05841407
Nitrate and Exercise Performance in Middle to Older Aged Adults
NCT03371966
The Effect of Beetroot Juice Supplementation Dose on Neuromuscular Performance During Resistance Exercise
NCT05957835
Effects of Isotonic Beetroot Supplementation on Sprint Interval Exercise Performance
NCT06349018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The use of dietary NO3 supplementation has been explored in the literature for mainly improving blood pressure, endothelial function, insulin response, and vascular effects in healthy/obese subjects. However, the metabolic effects of dietary NO3 for improving skeletal muscle glucose/lipid metabolism, muscle mitochondrial energetics, muscle blood flow, and body fat composition are not well studied in diabetic/pre-diabetic subjects.
In view of the potential health benefits of NO3/NO, this study plans to evaluate the therapeutic efficacy of a natural supplement, beetroot juice (rich in NO3) for improving the skeletal muscle mitochondrial function, muscle energetics, insulin sensitivity/glucose homeostasis, body fat composition and overall metabolism in middle aged (40 - 65 years) healthy and pre-diabetic male subjects. This would be the very first pilot study in the domain of metabolic diseases to evaluate the overall metabolic health of both obese pre-diabetic and non-diabetic male subjects using an advanced and comprehensive multi-model metabolic imaging approach.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
Subjects will consume 140mL of beetroot juice per day (800mg NO3/day), taken twice a day (70mL) in the afternoon and evening.
Beetroot juice
Single-centre, two-arm study involving 16 weeks of beetroot juice supplementation
Pre-diabetic
Subjects will consume 140mL of beetroot juice per day (800mg NO3/day), taken twice a day (70mL) in the afternoon and evening.
Beetroot juice
Single-centre, two-arm study involving 16 weeks of beetroot juice supplementation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beetroot juice
Single-centre, two-arm study involving 16 weeks of beetroot juice supplementation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body mass index (BMI) 23 - 30 kg/m2
3. Glucose metabolism: a. Normal group with having FPG \< 5.6 mmol/L and HbA1c \< 5.7, b. Pre-diabetes group FPG 5.6 to 6.9 mmol/L, and HbA1c \< 6.5 %.
4. Willing to refrain from using oral mouth wash during study participation
5. Willing to adhere to study protocol
Exclusion Criteria
2. Suffering from current oral health conditions such as gum diseases, oral cancer or mouth injury
3. Having medication and/or supplements which are known to influence glucose and insulin and muscle mitochondrial metabolism (e.g. Vitamin A, B, C and D, peroral corticosteroids)
4. Having medication for oral health conditions in the last 4 weeks and/or using oral mouth wash (e.g Listerine) in the last 2 weeks
5. Uncontrolled hypertension (blood pressure \> 160/100 mmHg)
6. Current smoker or excessive alcohol intake (\>4 standard drinks per day)
7. Known allergy/intolerance to beetroot family (eg: beetroot, spinach)
8. Undergoing weight loss diet and/or programs
9. Having contraindications for MRI e.g. metallic implants such as cardiac pacemaker
10. Receiving antibiotics or suffering from diarrhoea in the last 4 weeks
11. Consuming supplement(s) which contains nitrate
40 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Human Development and Potential (IHDP), Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yaligar Jadegoud
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yaligar Jadegoud, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute for Human Development and Potential (IHDP), Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore Institute for Clinical Sciences
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/00194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.